| Literature DB >> 29789672 |
Zhichao Huang1, Lu Yi1, Zhaohui Zhong1, Liang Zhu1, Hongqing Zhao1, Yijian Li1, Yeqi Nian1, Peng Xu1, Yinhuai Wang2.
Abstract
Fast-track surgery (FTS), which includes a series of evidence-based adjustments, is expected to reduce complications, relieve surgical stress reaction, accelerate recovery, and shorten hospitalization, as well as improve safety. The aim of this study was to critically evaluate the safety and effectiveness of FTS in Chinese prostate cancer (Pca) patients who underwent robot-assisted laparoscopic prostatectomy (RALP). A retrospective analysis was performed on 73 consecutive Chinese Pca patients who underwent RALP and who were divided into two groups: conventional surgery (CS) and FTS. Preoperative clinical data, intraoperative characteristics, postoperative outcomes and incidence of complications were compared between the two groups. No significant differences in preoperative parameters were observed between the two groups. Compared with the CS group, the FTS group showed a significantly shorter time to first flatus, time to regular diet, postoperative hospitalization time, lower incidence of complications, and lower reactions of postoperative stress and pain. Our study demonstrates that FTS is feasible and safe for Chinese Pca patients undergoing RALP and that it accelerates recovery, attenuates surgical stress response, and reduces morbidity compared to CS.Entities:
Mesh:
Year: 2018 PMID: 29789672 PMCID: PMC5964157 DOI: 10.1038/s41598-018-26372-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Protocols of the conventional and FTS groups.
| CS group | FTS group | |
|---|---|---|
| Preoperative education | Information about RALP surgery | Detailed information on the FTS protocol, Pca, and RALP surgery |
| Preoperative bowel preparation | Streptomycin (oral 1.0 g tid 2 d) and metronidazole (oral 0.4 g tid 2 d) were given. | Clear liquid diet on the day before surgery |
| Preoperative fasting | A mandatory overnight 12 h fast was performed before surgery. | A mandatory fast starting 6 h before surgery. |
| Intraoperative fluid infusion | Liberal protocol | Restricted protocol (5 ml/kg/h) |
| Postoperative fluid infusion | 3000–5000 ml the day of surgery followed by 2500–3000 ml for the next 3–4 d | 1000–2000 ml per day for 2–3 d |
| Postoperative mobilization | Based on patient’s desire | Encourage mobilization as soon as possible |
| Postoperative analgesia | Opium analgesics were used on demand. | A single dose of parecoxib 40 mg I.V. on the day of surgery followed by 20 mg I.V. every 12 h for the next 72 h |
| Postoperative diet | Allowed normal liquid and diet after first flatus | Chewing gum after surgery; POD 2: clear liquid diet; POD 3: semiliquid diet; POD 4: normal diet |
Preoperative characteristics of the patients.
| CS group (n = 37) | FTS group (n = 36) |
| |
|---|---|---|---|
| Age (years)* | 63.5 ± 7.4 (45–75) | 62.1 ± 6.9 (46–74) | 0.399 |
| BMI (kg/m2)# | 23.5 ± 2.2 (17.9–27.1) | 23.1 ± 2.1 (18.1–26.9) | 0.440 |
| PSA (ng/ml) | 15.40 ± 10.59 (4.10–45.55) | 13.44 ± 8.01 (4.22–44.15) | 0.377 |
| Gleason score | 0.935 | ||
| <7 | 16 | 17 | |
| 3 + 4 | 8 | 6 | |
| 4 + 3 | 6 | 7 | |
| >7 | 7 | 6 | |
| Clinical stage | 0.415 | ||
| T1 | 20 | 16 | |
| T2 | 17 | 20 | |
| ASA | 0.663 | ||
| I | 16 | 14 | |
| II | 15 | 15 | |
| III | 6 | 7 |
*Mean ± standard deviation (range); #BMI: body mass index.
Intraoperative and postoperative outcomes.
| CS group (n = 37) | FTS group (n = 36) |
| |
|---|---|---|---|
| Operative time (min) | 147 ± 29 (98–251) | 135 ± 32 (91–268) | 0.801 |
| Estimated blood loss (ml) | 179 ± 65 (50–310) | 191 ± 64 (55–330) | 0.456 |
| Time to first flatus (d) | 3.6 ± 1.5 (1.0–6.0) | 2.6 ± 1.1 (1.0–5.0) | 0.001 |
| Time to regular diet (d) | 5.9 ± 2.1 (2.0–10.0) | 4.2 ± 1.7 (2.0–10.0) | <0.001 |
| Postoperative hospital stay (d) | 9.8 ± 2.0 (6.0–15.0) | 7.3 ± 1.6 (5.0–14.0) | <0.001 |
| pain (n)* | 15 | 4 | 0.004 |
| Complications (Clavien grade I-II, n) | 15 | 6 | 0.025 |
| Nausea | 4 | 2 | |
| Lymphocele | 1 | 1 | |
| Urinary leakage | 2 | 1 | |
| Ileus | 3 | 1 | |
| Wound infection | 1 | 1 | |
| Urinary tract infection | 1 | 0 | |
| Pneumonia | 2 | 0 | |
| Deep venous thrombosis | 1 | 0 |
*Patients who needed opium analgesics.
Preoperative and postoperative values of WBC and serum CRP.
| WBC (×109/L) |
| Serum CRP (mg/L) |
| |||
|---|---|---|---|---|---|---|
| CS group | FTS group | CS group | FTS group | |||
| Preoperative | 6.86 ± 1.38 (4.30–9.12) | 6.67 ± 1.52 (4.22–9.72) | 0.585 | 3.52 ± 1.17 (1.09–5.79) | 3.33 ± 1.07 (1.22–5.68) | 0.482 |
| POD 1 | 15.16 ± 3.28 (8.48–19.89) | 14.82 ± 2.83 (9.47–19.21) | 0.638 | 81.11 ± 12.02 (44.79–98.76) | 79.37 ± 11.94 (49.71–101.36) | 0.536 |
| POD 3 | 12.13 ± 2.26 (7.21–15.67) | 11.80 ± 2.14 (7.70–16.54) | 0.531 | 57.06 ± 12.20 (27.81–71.33) | 55.60 ± 12.61 (25.91–76.93) | 0.618 |
| POD 5 | 9.29 ± 1.51 (6.77–12.56) | 7.97 ± 1.23 (5.12–11.31) | <0.001 | 24.21 ± 5.73 (15.81–43.17) | 15.76 ± 4.47 (6.98–30.87) | <0.001 |
| POD 7 | 8.03 ± 0.93 (5.47–9.61) | 6.51 ± 1.02 (4.81–8.47) | <0.001 | 12.18 ± 2.51 (7.77–16.92) | 8.40 ± 2.11 (4.67–12.13) | <0.001 |